UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Combined Administration of ( R )-Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Induces Rapid and Sustained Effects in the CUMS Model of Depression via a TrkB/BDNF-Dependent Mechanism

Pharmaceuticals (Basel, Switzerland), 2022-01, Vol.15 (2), p.125

2022

Volltextzugriff (PDF)

Subchronic administration of scopolamine reverses UCMS-induced behavior in mice via eEF2 protein dephosphorylation

Pharmacological reports, 2024-07

2024

Volltextzugriff (PDF)

Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies

International journal of molecular sciences, 2021-11, Vol.22 (22), p.12282

2021

Volltextzugriff (PDF)

Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats

Psychopharmacology, 2016-08, Vol.233 (15-16), p.2901-2914

2016

Volltextzugriff (PDF)

On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039

Psychopharmacologia, 2010-12, Vol.212 (4), p.523-535

2010

Volltextzugriff (PDF)

Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu7 Receptor Modulation Activity and Antipsychotic-Like Properties

International journal of molecular sciences, 2023-01, Vol.24 (3), p.1981

2023

Volltextzugriff (PDF)

New 1,2,4-oxadiazole derivatives with positive mGlu4 receptor modulation activity and antipsychotic-like properties

Journal of enzyme inhibition and medicinal chemistry, 2022-12, Vol.37 (1), p.211-225

2022

Volltextzugriff (PDF)

The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent

The Journal of pharmacology and experimental therapeutics, 2010-09, Vol.334 (3), p.1066

2010

Volltextzugriff (PDF)

Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs

Frontiers in molecular neuroscience, 2018-09, Vol.11, p.316-316

2018

Volltextzugriff (PDF)

Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes

Cancer Immunology, Immunotherapy, 2006-07, Vol.55 (7), p.808-818

2006

Volltextzugriff (PDF)

mGlu5-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia

Neurochemistry international, 2015-09, Vol.88, p.97-109

2015

Volltextzugriff (PDF)

The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test

Progress in neuro-psychopharmacology & biological psychiatry, 2009-03, Vol.33 (2), p.323-329

2009

Volltextzugriff (PDF)

Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems

Neuropharmacology, 2010-12, Vol.59 (7), p.627-634

2010

Volltextzugriff (PDF)

The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent

Psychopharmacology, 2014, Vol.231 (1), p.97-107

2014

Volltextzugriff (PDF)

Is the mGlu5 receptor a possible target for new antidepressant drugs?

Pharmacological reports, 2013-01, Vol.65 (6), p.1506-1511

2013

Volltextzugriff (PDF)

Tetracycline-Based System for Controlled Inducible Expression of Group III Metabotropic Glutamate Receptors

Journal of biomolecular screening, 2015-03, Vol.20 (3), p.350-358

2015

Volltextzugriff (PDF)

Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist

Pharmacology, biochemistry and behavior, 2005-08, Vol.81 (4), p.901-906

2005

Volltextzugriff (PDF)

Indole-like heterocyclic compounds as a new core structure in search of potential allosteric modulators of group III metabotropic glutamate receptors

Pharmacological reports, 2012-03, Vol.64 (2), p.505-505

2012

Volltextzugriff (PDF)

Identification and characterization of new 5-HT7 receptor inverse agonists

Pharmacological reports, 2012-03, Vol.64 (2), p.502-502

2012

Volltextzugriff (PDF)

Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex

Brain research, 2007-12, Vol.1184, p.88-95

2007

Volltextzugriff (PDF)

Chronic imipramine treatment reduces inhibitory properties of group II mGlu receptors without affecting their density or affinity

Pharmacological reports, 2007-09, Vol.59 (5), p.525-530

2007

Volltextzugriff (PDF)

Antidepressant-like activity of 8-Br-cAMP, a PKA activator, in the forced swim test

Journal of Neural Transmission, 2008-06, Vol.115 (6), p.829-830

2008

Volltextzugriff (PDF)

Simultaneous activation of mGlu2 and muscarinic receptors reverses MK-801-induced cognitive decline in rodents

Neuropharmacology, 2020-09, Vol.174, p.107866-107866, Article 107866

2020

Volltextzugriff (PDF)

In the Amygdala Anxiolytic Action of mGlu5 Receptors Antagonist MPEP Involves Neuropeptide Y but not GABAA Signaling

Neuropsychopharmacology (New York, N.Y.), 2004-03, Vol.29 (3), p.514-521

2004

Volltextzugriff (PDF)

The functional cooperation of 5-HT1A and mGlu4R in HEK-293 cell line

Pharmacological reports, 2020-10, Vol.72 (5), p.1358-1369

2020

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(62)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Animals
(33)
Male
(27)
Pharmacology & Pharmacy
(25)
Rats
(23)
Neurosciences
(19)
Neurosciences & Neurology
(17)
Rats, Wistar
(17)
Drug Safety And Pharmacovigilance
(16)
Pharmacotherapy
(16)
Pharmacy
(16)
Mice
(15)
Biological And Medical Sciences
(14)
Dose-Response Relationship, Drug
(12)
Motor Activity - Drug Effects
(12)
Psychopharmacology
(11)
Receptors, Metabotropic Glutamate - Metabolism
(11)
Antidepressive Agents - Pharmacology
(10)
Medical Sciences
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Combined Administration of ( R )-Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Induces Rapid and Sustained Effects in the CUMS Model of Depression via a TrkB/BDNF-Dependent Mechanism

Subchronic administration of scopolamine reverses UCMS-induced behavior in mice via eEF2 protein dephosphorylation

Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies

Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats

On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039

Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu7 Receptor Modulation Activity and Antipsychotic-Like Properties

New 1,2,4-oxadiazole derivatives with positive mGlu4 receptor modulation activity and antipsychotic-like properties

The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent

Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs

Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes

mGlu5-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia

The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test

Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems

The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent

Is the mGlu5 receptor a possible target for new antidepressant drugs?

Tetracycline-Based System for Controlled Inducible Expression of Group III Metabotropic Glutamate Receptors

Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist

Indole-like heterocyclic compounds as a new core structure in search of potential allosteric modulators of group III metabotropic glutamate receptors

Identification and characterization of new 5-HT7 receptor inverse agonists

Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex

Chronic imipramine treatment reduces inhibitory properties of group II mGlu receptors without affecting their density or affinity

Antidepressant-like activity of 8-Br-cAMP, a PKA activator, in the forced swim test

Simultaneous activation of mGlu2 and muscarinic receptors reverses MK-801-induced cognitive decline in rodents

In the Amygdala Anxiolytic Action of mGlu5 Receptors Antagonist MPEP Involves Neuropeptide Y but not GABAA Signaling

The functional cooperation of 5-HT1A and mGlu4R in HEK-293 cell line

Suchergebnisse filtern